Atox Bio Ltd.
Atox Bio and Fast-Track Drugs & Biologics Sign an R&D Collaboration Agreement for the Development of Therapeutics for Sepsis and Septic Shock
Published in Blood Weekly, July 9th, 2009
Atox Bio Ltd., a subsidiary of Yissum Research Development Company Ltd., and Fast-Track Drugs & Biologics LLC announced the initiation of a joint R&D program to continue the development of Atox Bio's novel mechanism-based immunomodulator peptide, AB103, for the treatment of sepsis and septic shock. The collaboration includes advanced pre-clinical studies and a Phase I clinical trial to be performed at the University of Maryland, Baltimore, U.S.A. The collaborative R&D program has won the support of the Israel-U.S. Binational Industrial Research and Development Fund (BIRD) for the amount of $575,000.
AB103 is a novel mechanism-based immunomodulator that attenuates the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2009-07-09)
More Articles from Blood Weekly
- Acute Myelogenous Leukemia
Studies from University of Pittsburgh update current data on acute myelogenous leukemia - Antibiotics
Studies from P.I. Rafailidis et al add new findings in the area of antibiotics - BloodCenter of Wisconsin
BloodCenter of Wisconsin’s New Genetic Test Identifies People at High Risk for Developing Inherited Form of Leukemia - Cancer
Research from National Cancer Institute has provided new data on cancer - Cancer
Studies from A.A. Morales et al have provided new data on cancer - Chorioamnionitis
Data on chorioamnionitis detailed by researchers at Maastricht University - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
